A detailed history of Ckw Financial Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Ckw Financial Group holds 30 shares of ABBV stock, worth $7,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$7,020
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 16, 2025

SELL
$169.2 - $216.66 $874,256 - $1.12 Million
-5,167 Reduced 99.42%
30 $6,000
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $1,376 - $1,549
10 Added 0.19%
5,197 $805,000
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $684,679 - $852,038
5,167 Added 25835.0%
5,187 $699,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $2,892 - $3,330
20 New
20 $3,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ckw Financial Group Portfolio

Follow Ckw Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ckw Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Ckw Financial Group with notifications on news.